Cargando…
Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma
BACKGROUND: Rhabdomyosarcoma (RMS) is a malignant soft-tissue tumour. In recent years, the tumour microenvironment (TME) has been reported to be associated with the development of tumours. However, the relationship between the occurrence and development of RMS and TME is unclear. The purpose of this...
Autores principales: | Xia, Tian, Meng, Lian, Zhao, Zhijuan, Li, Yujun, Wen, Hao, Sun, Hao, Zhang, Tiantian, Wei, Jingxian, Li, Feng, Liu, Chunxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626952/ https://www.ncbi.nlm.nih.gov/pubmed/34838000 http://dx.doi.org/10.1186/s12935-021-02347-3 |
Ejemplares similares
-
CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis
por: Li, Qianru, et al.
Publicado: (2019) -
CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a
bioinformatics study
por: Li, An-hai, et al.
Publicado: (2022) -
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1
por: Gu, Junsheng, et al.
Publicado: (2019) -
Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma
por: Lu, Suying, et al.
Publicado: (2020) -
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
por: Ouchi, Kazutaka, et al.
Publicado: (2020)